In a significant legal victory for Bayer, the U.S. Supreme Court has issued a 7-2 ruling that effectively shuts down thousands of lawsuits alleging that the company’s Roundup weedkiller causes cancer. The decision limits the ability of plaintiffs to sue under state law for “failure-to-warn,” marking a pivotal shift in the long-standing litigation surrounding the agrochemical giant.
The ruling centers on the federal pesticide law, which the justices determined preempts state-level claims. Because the U.S. Environmental Protection Agency (EPA) has consistently maintained that glyphosate—the active ingredient in Roundup—is not likely to cause cancer in humans, the court found that federal law does not require a cancer warning label. Consequently, companies cannot be penalized under state laws for failing to include a warning that federal authorities explicitly forbid.
Justice Brett Kavanaugh, writing for the majority, emphasized that requiring Monsanto to add a cancer warning to the product label would directly conflict with the EPA-approved labeling requirements. By siding with Bayer, the high court has provided a robust legal shield for the company, which has been mired in a tidal wave of litigation since its $63 billion acquisition of Monsanto in 2018.
The decision resulted in an immediate positive market reaction, with Bayer shares surging nearly 18 percent. The ruling specifically overturned a $1.25 million jury verdict awarded to John Durnell, a plaintiff who alleged that his non-Hodgkin lymphoma was caused by years of exposure to the herbicide.
Despite the majority’s stance, the decision drew sharp criticism from the bench. Justice Ketanji Brown Jackson, joined by Justice Neil Gorsuch, issued a stinging dissent. Jackson argued that the ruling “unjustifiably closes the courthouse doors to state tort plaintiffs,” contending that state-level requirements should be able to coexist with federal standards.
While the ruling is a massive relief for Bayer, it presents a complex political landscape. Although the Trump administration previously supported the company’s position, the current political climate—including the burgeoning “Make America Healthy Again” movement—has placed renewed scrutiny on pesticide use, leaving the long-term public perception of the product in flux.
Summary:
1. The Supreme Court ruled 7-2 in favor of Bayer, blocking state-level “failure-to-warn” lawsuits.
2. The court cited federal preemption, noting the EPA does not require cancer warnings on Roundup.
3. The ruling overturned a $1.25 million verdict for a cancer patient.
4. Bayer’s stock price jumped nearly 18% following the announcement.
5. Justices Jackson and Gorsuch dissented, criticizing the limitation on state tort claims.
Comments (0)